ATOSSA THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.1M | $141.3M | $136.4M |
| FY2022 | $5.6M | $123.5M | $110.9M |
| FY2023 | $5.2M | $96.3M | $88.5M |
| FY2024 | $5.0M | $76.4M | $71.1M |
| FY2025 | $8.3M | $47.6M | $41.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.1M | $141.3M | $136.4M |
| FY2022 | $5.6M | $123.5M | $110.9M |
| FY2023 | $5.2M | $96.3M | $88.5M |
| FY2024 | $5.0M | $76.4M | $71.1M |
| FY2025 | $8.3M | $47.6M | $41.3M |